Ted Hibben
Keine laufenden Positionen mehr
Profil
Ted Hibben worked as VP-Business Development & Alliance Management at Coley Pharmaceutical Group, Senior Vice President-Corporate Development at Ensemble Therapeutics Corp., Chief Business Officer at Cequent Pharmaceuticals, Consultant at Elixir Pharmaceuticals, and Principal at Pericor Science.
He received his undergraduate degree from Dartmouth College and his MBA from Harvard University.
Ehemalige bekannte Positionen von Ted Hibben
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.08.2018 |
Pericor Science, Inc.
 Pericor Science, Inc. Pharmaceuticals: MajorHealth Technology Pericor Science, Inc. develops novel therapeutic products. It manufactures renal cell therapy devices. The company was founded by Howard Green and Philippe Djian in 1999 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01.01.2002 |
Ensemble Therapeutics Corp.
 Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Elixir Pharmaceuticals, Inc.
 Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Cequent Pharmaceuticals, Inc.
 Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Ted Hibben
| Dartmouth College | Undergraduate Degree |
| Harvard University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
Cequent Pharmaceuticals, Inc.
Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Health Technology |
Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA. | Miscellaneous |
Pericor Science, Inc.
Pericor Science, Inc. Pharmaceuticals: MajorHealth Technology Pericor Science, Inc. develops novel therapeutic products. It manufactures renal cell therapy devices. The company was founded by Howard Green and Philippe Djian in 1999 and is headquartered in Waltham, MA. | Health Technology |
Ensemble Therapeutics Corp.
Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Process Industries |
